- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 2 x IPE: 3-METHYLBUT-3-ENYL TRIHYDROGEN DIPHOSPHATE(Non-covalent)
IPE.4: 12 residues within 4Å:- Chain A: G.58, K.59, R.62, Q.98, R.115, T.203, Y.206, S.207, F.241, Q.242, D.245
- Ligands: ZOL.5
18 PLIP interactions:18 interactions with chain A- Hydrophobic interactions: A:T.203, A:F.241, A:D.245
- Hydrogen bonds: A:K.59, A:R.62, A:Q.98
- Water bridges: A:K.59, A:K.59, A:K.59, A:Y.60, A:Y.60, A:Y.60, A:Y.60, A:R.62
- Salt bridges: A:K.59, A:K.59, A:R.62, A:R.115
IPE.9: 12 residues within 4Å:- Chain B: G.58, K.59, R.62, Q.98, R.115, T.203, Y.206, S.207, F.241, Q.242, D.245
- Ligands: ZOL.10
18 PLIP interactions:18 interactions with chain B- Hydrophobic interactions: B:T.203, B:F.241, B:D.245
- Hydrogen bonds: B:K.59, B:R.62, B:Q.98
- Water bridges: B:K.59, B:K.59, B:K.59, B:Y.60, B:Y.60, B:Y.60, B:Y.60, B:R.62
- Salt bridges: B:K.59, B:K.59, B:R.62, B:R.115
- 2 x ZOL: ZOLEDRONIC ACID(Non-covalent)
ZOL.5: 13 residues within 4Å:- Chain A: D.105, D.109, R.114, Q.173, K.202, T.203, Q.242, D.245, K.259
- Ligands: MG.1, MG.2, MG.3, IPE.4
12 PLIP interactions:12 interactions with chain A- Hydrogen bonds: A:D.109, A:D.109, A:R.114, A:R.114, A:Q.242, A:D.245
- Water bridges: A:S.111, A:S.111, A:Q.173, A:K.202, A:K.202, A:D.249
ZOL.10: 13 residues within 4Å:- Chain B: D.105, D.109, R.114, Q.173, K.202, T.203, Q.242, D.245, K.259
- Ligands: MG.6, MG.7, MG.8, IPE.9
11 PLIP interactions:11 interactions with chain B- Hydrogen bonds: B:D.109, B:R.114, B:R.114, B:Q.242, B:D.245
- Water bridges: B:S.111, B:S.111, B:Q.173, B:K.202, B:K.202, B:K.259
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kavanagh, K.L. et al., The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs. Proc.Natl.Acad.Sci.USA (2006)
- Release Date
- 2005-06-28
- Peptides
- farnesyl diphosphate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 2 x IPE: 3-METHYLBUT-3-ENYL TRIHYDROGEN DIPHOSPHATE(Non-covalent)
- 2 x ZOL: ZOLEDRONIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kavanagh, K.L. et al., The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs. Proc.Natl.Acad.Sci.USA (2006)
- Release Date
- 2005-06-28
- Peptides
- farnesyl diphosphate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A